# Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer

> **NCT00096668** · PHASE2 · COMPLETED · sponsor: **Achieve Life Sciences** · enrollment: 47 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** TOCOSOL(R) Paclitaxel

## Key facts

- **NCT ID:** NCT00096668
- **Lead sponsor:** Achieve Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2009-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00096668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00096668, "Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00096668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*